Fukutome Meat Packers Ltd. logo

Fukutome Meat Packers Ltd. (2291)

Market Closed
10 Aug, 06:00
JPX JPX
¥
512. 00
-1
-0.1949%
¥
- Market Cap
- P/E Ratio
2.5% Div Yield
800 Volume
- Eps
¥ 513
Previous Close
Add Transaction
Day Range
512 513
Year Range
468 1,117
Want to track 2291 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2291 closed yesterday lower at ¥512, a decrease of -0.1949% from Friday's close, completing a monthly increase of 6.6667% or ¥32. Over the past 12 months, 2291 stock lost -15.7895%.
2291 pays dividends to its shareholders, with the most recent payment made on Jul 31, 2026. The next estimated payment will be in In 11 months on Jul 31, 2027 for a total of ¥0.57255.
The last earnings report, released on May 19, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Fukutome Meat Packers Ltd. has completed 1 stock splits, with the recent split occurring on Sep 27, 2017.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2291 Chart

Fukutome Meat Packers Ltd. (2291) FAQ

What is the stock price today?

The current price is ¥512.00.

On which exchange is it traded?

Fukutome Meat Packers Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 2291.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.5%.

What is its market cap?

As of today, no market cap data is available.

Has Fukutome Meat Packers Ltd. ever had a stock split?

Fukutome Meat Packers Ltd. had 1 splits and the recent split was on Sep 27, 2017.

Fukutome Meat Packers Ltd. Profile

Health Care Technology Industry
Healthcare Sector
- CEO
JPX Exchange
JP3806600007 ISIN
China Country
239 Employees
27 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., established in 1994 and headquartered in Shanghai, China, operates as an investment holding company with a global reach in the medical technology sector. The company is deeply engaged in the research, development, manufacture, and commercialization of interventional medical devices, offering advanced solutions for the treatment of various cardiovascular and congenital heart conditions. As a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd., LEPU ScienTech has carved a niche for itself by specializing in an array of interventional medical devices that cater to the needs of hospitals and distributors worldwide.

Products and Services

  • Congenital Heart Diseases Interventional Treatment Solutions

    LEPU ScienTech provides a comprehensive range of products designed for the treatment of congenital heart diseases. This includes occluder products for atrial septal defects, ventricular septal defects, and patent ductus arteriosus. Additionally, the company offers specialized delivery systems and snare products to support the deployment of these treatments.

  • Cardioembolic Stroke Prevention Solutions

    The company’s portfolio includes left atrial appendage and patent foramen ovale occluder products, aimed at preventing strokes that may be caused by blood clots originating from the heart. These products are crucial for patients at risk of cardioembolic strokes, providing an effective preventive measure.

  • Treatment of Valvular Disease Solutions

    Offering a range of products for the treatment of valvular diseases, LEPU ScienTech has developed solutions for aortic, mitral, tricuspid, and pulmonary valve conditions. These include various valve products and procedural accessories essential for the successful treatment of valve-related heart diseases.

  • Vascular Plugs and Interatrial Shunt Devices

    The company also manufactures vascular plugs and interatrial shunt devices, which are used to control abnormal blood flow within the heart or between blood vessels. These innovative devices are crucial for patients needing precise management of their blood flow to prevent or treat various cardiovascular conditions.

Contact Information

Address: Building 41
Phone: 86 21 3701 5600